Patent · US Expired

1,4,5-triphenylimidazol-2-yl mercapto alkanoic acids, useful against inflammation and diseases responding to lipid lowering

US4654358A · kind A · utility

5Cited by
2References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 25, 1984
Grant dateMar 31, 1987
Priority date
Expiry dateJun 25, 2004

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is related to imidazol-2-yl mercapto alkanoic acids having the formula I ##STR1## process for the treatment of humans suffering from inflammatory diseases or diseases in relation with the lipid metabolism.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.